WESLEY RAY: Open Payments
NPI 1063403434 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,207 in 64 payments from 15 companies in 2025. Trend: 2023 $1,092 · 2024 $1,014 · 2025 $1,207
Food & beverage: $1,207
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $370 |
| ABBVIE INC. | 12 | $175 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $142 |
| Lilly USA, LLC | 6 | $98 |
| GlaxoSmithKline, LLC. | 4 | $85 |
| Astellas Pharma US Inc | 3 | $84 |
| PFIZER INC. | 3 | $63 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $55 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| Phathom Pharmaceuticals, Inc. | 2 | $23 |
Products named: Ozempic, TRINTELLIX, VRAYLAR, MOUNJARO, Wegovy, TRELEGY ELLIPTA, Veozah, JARDIANCE.
Industry payments across TN — which companies pay providers there.
